Effect of Exercise Training Modality on C-reactive Protein in Type 2 Diabetes
Overview
Affiliations
Purpose: Type 2 diabetes is associated with increased risk of cardiovascular disease and elevated C-reactive protein (CRP) levels. Aerobic exercise training has been shown to improve CRP; however, there are limited data evaluating the effect of other exercise training modalities (aerobic, resistance, or combination training) in individuals with type 2 diabetes.
Methods: Participants (n = 204) were randomized to an aerobic exercise (aerobic), resistance exercise (resistance), or a combination of both (combination) for 9 months. CRP was evaluated at baseline and at follow-up.
Results: Baseline CRP was correlated with fat mass, waist circumference, body mass index, and VO(2peak) ̇(P < 0.05). CRP was not reduced after aerobic (0.16 mg·L(-1), 95% confidence interval (CI) = -1.0 to 1.3 mg·L(-1)), resistance (-0.03 mg·L(-1), 95% CI = -1.1 to 1.0 mg·L(-1)), or combination (-0.49 mg·L(-1), 95% CI = -1.5 to 0.6 mg·L(-1)) training compared to control (0.35 mg·L(-1), 95% CI = -1.0 to 1.7 mg·L(-1)). Changes in fasting glucose (r = 0.20, P = 0.009), glycated hemoglobin (HbA1c) (r = 0.21, P = 0.005), and fat mass (r = 0.19, P = 0.016) were associated with reductions in CRP but not with change in fitness or weight (P > 0.05). There were significant trends observed for CRP among tertiles of change in HbA1c (P = 0.009) and body fat (P = 0.040).
Conclusions: Aerobic, resistance, or a combination of both did not reduce CRP levels in individuals with type 2 diabetes. However, exercise-related improvements in HbA1c, fasting glucose, and fat mass were associated with reductions in CRP.
Sun Y, Sun M, Zeng X, Xiang Je L, Su Guo Z Acta Diabetol. 2024; 62(1):11-24.
PMID: 39692776 DOI: 10.1007/s00592-024-02413-y.
Garcia-Hermoso A, Ezzatvar Y, Yanez-Sepulveda R, Olivares-Arancibia J, Paez-Herrera J, Lopez-Gil J BMJ Open Sport Exerc Med. 2024; 10(4):e002229.
PMID: 39659710 PMC: 11628982. DOI: 10.1136/bmjsem-2024-002229.
Al-Mhanna S, Batrakoulis A, Ghazali W, Mohamed M, Aldayel A, Alhussain M PeerJ. 2024; 12:e17525.
PMID: 38887616 PMC: 11182026. DOI: 10.7717/peerj.17525.
Kim Y, Campbell J, Johannsen N, Church T, Cho E, Heaney J Front Physiol. 2024; 15:1328470.
PMID: 38725572 PMC: 11079445. DOI: 10.3389/fphys.2024.1328470.
Role of C-Reactive Protein in Kidney Diseases.
Li J, Chen J, Lan H, Tang Y Kidney Dis (Basel). 2023; 9(2):73-81.
PMID: 37065607 PMC: 10090978. DOI: 10.1159/000528693.